Poster Viewing - coffee and biscuits

Posters may be freely browsed

SESSION 3: Circulating tumor cells

Chair: Evi Lianidou

Industry Spotlight - Precision For Medicine

Darren Davis Precision For Medicine

“Using Circulating Tumor Cells as Pharmacodynamic Biomarkers in Clinical Trials”

Q&A: 09:20 - 09:30

Haichao Wang University of Cambridge, UK

Proffered Paper 2: "cfDNAPro: an R/Bioconductor package to characterise and visualise cell-free DNA biological features in liquid biopsy"

Q&A: 09:40 - 09:45

The EMBO Keynote Lecture

Caroline Dive CRUK Manchester Institute, UK

"Circulating Tumour Cells in Lung Cancer"

Q&A: 10:05 - 10:15

Claus Jørgensen CRUK Manchester Institute, UK

“The phenotypic landscape of circulating tumour cells in pancreatic ductal adenocarcinoma patients”

Q&A: 10:35 - 10:45

Coffee Break & Exhibition

Nicola Aceto ETH Zurich, Switzerland

“Biology and vulnerabilities of circulating tumor cell clusters”

Q&A: 11:35 - 11:45

Francesco Gatto Elypta, Sweden

Proffered Paper 3: "Multi-cancer early detection using non-invasive profiling of free glycosaminoglycans as biomarkers of tumor metabolism"

Q&A: 11:55 - 12:00

Poster Spotlights

3 top abstracts presented as 3 minute flash talks

Industry Symposium - Thermo Fisher Scientific

David Guttery

"Verification of an NGS approach for earlier detection of endometrial cancer relapse using liquid biopsies"

Lunch & Exhibition

Poster Discussion Session 2 (Posters 56 - 108)

Milana Frenkel-Morgenstern Bar-Ilan University, Israel

"Liquid Biopsy using gene-gene fusions in Complex Diseases"

Q&A: 15:25 - 15:35

Daniel Haber Harvard Medical School, USA (Presenting remotely)

"Functional Annotation of Circulating Tumor Cells"

Q&A: 15:55 - 16:05

Roni Ben Ami The Hebrew University of Jerusalem, Israel

Proffered Paper 4: "Protein biomarkers and alternatively methylated cell-free DNA for detection of early-stage pancreatic cancer"

Q&A: 16:15 - 16:20

Efrat Shema Weizmann Institute of Science, Israel

Proffered Paper 5: "Multiplexed Single-Molecule Epigenetic Analysis of Plasma-Isolated Nucleosomes for Cancer Diagnostics"

Q&A: 16:30 - 16:35

Coffee Break & Exhibition

SESSION 4: ctDNA-MRD

Chair: Nickolas Papadopoulos

Ryan Corcoran Harvard Medical School, USA

“Clinical Applications of Liquid Biopsy to Detect Minimal Residual Disease”

Q&A: 17:25 - 17:35

Silvia Marsoni IFOM, Italy

"Interventional liquid biopsy in colorectal cancer"

Q&A: 17:55 - 18:05

Discussion Forum (40 minutes)

“Beyond ctDNA mutations, as a liquid biopsy for personalised cancer medicine”

Conference Dinner

Taverna Valtellinese

Optional ticketed dinner

Poster Viewing - coffee and biscuits

Posters may be freely browsed

Industry Spotlight - Novosanis

Amit Arora DNA Genotek

“Bridging the gap: moving urine as a liquid biopsy into clinical practice"

SESSION 5: CTDNA, Methylation & Fragmentomics

Chair: Caroline Dive

Dominic Rothwell CRUK Manchester Institute, UK

"Profiling of the cfDNA methylome for detection, monitoring and characterisation of cancer"

Q&A: 09:20 - 09:30

Sarah-Jane Dawson Peter Mac, Australia

“Genomic and Epigenomic Monitoring of Cancer Using Liquid Biopsies”

Q&A: 09:50 - 10:00

Coffee Break & Exhibition

Ellen Heitzer Medical University of Graz, Austria

"Genome-wide analysis of ctDNA for cancer monitoring and stratification"

Q&A: 10:50 - 11:00

Yari Ciani University of Trento, Italy

Proffered Paper 6: "Detection and tracking of breast cancer signal in the plasma of patients on neoadjuvant chemotherapy treatment via cfDNA and EV-RNA analysis"

Q&A: 11:10 - 11:15

Gabriella Sozzi Istituto Nazionale Tumori, Italy

"Liquid biopsy for screening and early detection of lung cancer"

Q&A: 11:35 - 11:45

Conference Summary & Depart